BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 22544211)

  • 41. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
    Mason EF; Hornick JL
    Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.
    Mason EF; Hornick JL
    Mod Pathol; 2013 Nov; 26(11):1492-7. PubMed ID: 23743927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
    Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
    Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.
    Douwes Dekker PB; Hogendoorn PC; Kuipers-Dijkshoorn N; Prins FA; van Duinen SG; Taschner PE; van der Mey AG; Cornelisse CJ
    J Pathol; 2003 Nov; 201(3):480-6. PubMed ID: 14595761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
    Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
    Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
    APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
    Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
    Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
    Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
    Pasini B; Stratakis CA
    J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
    Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
    [No Abstract]   [Full Text] [Related]  

  • 55. Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondria.
    Szarek E; Ball ER; Imperiale A; Tsokos M; Faucz FR; Giubellino A; Moussallieh FM; Namer IJ; Abu-Asab MS; Pacak K; Taïeb D; Carney JA; Stratakis CA
    Endocr Relat Cancer; 2015 Jun; 22(3):345-52. PubMed ID: 25808178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
    McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics of hereditary head and neck paragangliomas.
    Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
    Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic dichotomy in mitochondrial complex II genetic disorders.
    Baysal BE; Rubinstein WS; Taschner PE
    J Mol Med (Berl); 2001 Sep; 79(9):495-503. PubMed ID: 11692162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.